The genomic landscape of tuberous sclerosis complex

Katie R. Martin(Van Andel Institute), Wanding Zhou(Van Andel Institute), Megan J. Bowman(Van Andel Institute), Juliann Shih(Broad Institute), Kit Sing Au(The University of Texas Health Science Center), Kristin E. Dittenhafer‐Reed(Van Andel Institute), Kellie A. Sisson(Van Andel Institute), Julie Koeman(Van Andel Institute), Daniel J. Weisenberger(University of Southern California), Sandra Cottingham(Spectrum Health), Steven T. DeRoos(Spectrum Health), Orrin Devinsky(New York University), Mary E. Winn(Van Andel Institute), Andrew D. Cherniack(Broad Institute), Hui Shen(Van Andel Institute), Hope Northrup(The University of Texas Health Science Center), Darcy A. Krueger(Cincinnati Children's Hospital Medical Center), Jeffrey P. MacKeigan(Van Andel Institute)
Nature Communications
June 15, 2017
Cited by 238Open Access
Full Text

Abstract

Tuberous sclerosis complex (TSC) is a rare genetic disease causing multisystem growth of benign tumours and other hamartomatous lesions, which leads to diverse and debilitating clinical symptoms. Patients are born with TSC1 or TSC2 mutations, and somatic inactivation of wild-type alleles drives MTOR activation; however, second hits to TSC1/TSC2 are not always observed. Here, we present the genomic landscape of TSC hamartomas. We determine that TSC lesions contain a low somatic mutational burden relative to carcinomas, a subset feature large-scale chromosomal aberrations, and highly conserved molecular signatures for each type exist. Analysis of the molecular signatures coupled with computational approaches reveals unique aspects of cellular heterogeneity and cell origin. Using immune data sets, we identify significant neuroinflammation in TSC-associated brain tumours. Taken together, this molecular catalogue of TSC serves as a resource into the origin of these hamartomas and provides a framework that unifies genomic and transcriptomic dimensions for complex tumours.


Related Papers